Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7267 p358
20 September 2003

This article
Reprint
Photocopy


News summary

Related websites
Consultation on the reclassification of Canesten Combi (Microsoft Word document)


GSL application for Canesten Combi

Bayer wants Canesten Combi (Canesten 500mg pessary and 10g Canesten 2 per cent cream) to be a general sale list medicine.

Comments on Medicines and Healthcare products Regulatory Agency consultation document ARM 11 (available as a Microsoft Word document) can be made until 21 October.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal